One of the things that makes patient engagement for pharma companies so challenging is that it's not something that can be added to one step of a process and then checked off the list.
Value-based care is at the centre of industry discussions at the moment, not only advancing quality and equity in healthcare, but also accelerating innovation in care delivery.
When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, pr
Vision loss associated with diabetes is one of the more prevalent and growing healthcare burdens in the Western world.
We've recently passed the midpoint of 2024, so it's a good time to check in on trends – in this case, trends in the clinical trial space.
Editor's Picks
